23andme Holding Co logo

23andme Holding Co Share Price Today (NASDAQ: ME)

23andme Holding Co share price is $0 & ₹0.00 as on 26 Mar 2025 IST

▲

-0.77

(-100%)

Market is closed - opens 7 PM, 18 Jun 2025

Bell Icon

The stock has been delisted from the stock exchange on 27 Mar 2025

View live 23andme Holding Co share price in Dollar and Rupees. Guide to invest in 23andme Holding Co stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in 23andme Holding Co, along with analyst recommendations, forecasts, and comprehensive financials.

23andme Holding Co (ME) Key Statistics

in dollars & INR

Previous Close
$0.77
Open
$0.748
Market Capitalization
$15.2M
Today's Volume
$29.3M
Revenue TTM
$208.8M
EBITDA
$-219.7M
Earnings Per Share (EPS)
$-17.39
Profit Margin
-186.98%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-193.76%

How to invest in 23andme Holding Co Stock (ME) from India?

It is very easy for Indian residents to invest directly in 23andme Holding Co from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the 23andme Holding Co stock in both Indian Rupees (INR) and US Dollars (USD). Search for 23andme Holding Co or ME on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of 23andme Holding Co or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of 23andme Holding Co shares which would translate to null fractional shares of 23andme Holding Co as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like 23andme Holding Co, in just a few clicks!

Global Institutional Holdings in 23andme Holding Co

  • Vanguard Group Inc

    2.90%

  • Shay Capital LLC

    2.62%

  • Sapphire Ventures (GPE) I, L.L.C.

    0.99%

  • Jane Street Group LLC

    0.96%

  • BlackRock Inc

    0.89%

  • Millennium Management LLC

    0.83%

Analyst Recommendation on 23andme Holding Co

Rating
Trend

Buy

    80%Buy

    20%Hold

    0%Sell

Based on 10 Wall street analysts offering stock ratings for 23andme Holding Co(by analysts ranked 0 to 5 stars)

About 23andme Holding Co

23andMe Holding Co. operates as a consumer genetics testing company in the United States, the United Kingdom, Canada, and internationally. The company operates in two segments, Consumer and Research Services, and Therapeutics. The Consumer and Research Services segment provides personal genome service (PGS) that consists of a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications. This segments also operates Lemonaid telehealth platform to access affiliated licensed healthcare professionals for medical consultation and treatment for various common conditions; and offers research services. The Therapeutics segment focuses on the development of novel therapies; and research and development of programs in various therapeutic areas, such as oncology, immunological and inflammatory diseases, and other disease areas, as well as engages in the out-licensing of intellectual property associated with identified drug targets and expenses related to the discovery and development of therapeutic product candidates. This segment also comprises a therapeutics product portfolio, including 23ME-00610 (P006), a humanized monoclonal antibody that interfere with the ability of CD200R1 to interact with CD200 in cancer cells; GSK6097608, an immuno-oncology program for targeting CD96; and 23ME-01473 is an immuno-oncology antibody program that targets the ULBP6 proteins in the NKG2D pathway. The company has collaboration with Mirador Therapeutics to advance mirador's precision medicines for immunology and inflammation. 23andMe Holding Co. was founded in 2006 and is headquartered in South San Francisco, California. On March 23, 2025, 23andMe Holding Co., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Eastern District of Missouri.
Organization
23andme Holding Co
Employees
560
CEO
Mr. Guy Chayoun
Industry
Miscellaneous

Management People of 23andme Holding Co

NameTitle
Mr. Guy Chayoun
VP, Interim General Counsel & Corporate Secretary
Ms. Tracy Keim
Chief Marketing Officer
Ms. Savita Pillai
Vice President of People
Mr. Kent Hillyer
Vice President of Consumer Operations
Mr. Daniel Chu
Chief Product Officer
Mr. Frank Russo
Chief Security Officer

Important FAQs about investing in ME Stock from India :

Can Indians buy 23andme Holding Co shares?

Yes, Indians can invest in the 23andme Holding Co (ME) from India.

With INDmoney, you can buy 23andme Holding Co at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy 23andme Holding Co at zero transaction cost.

How can I buy 23andme Holding Co shares from India?

It is very easy to buy 23andme Holding Co from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of 23andme Holding Co (ME) be purchased?

Yes, you can buy fractional shares of 23andme Holding Co with INDmoney app.

What are the documents required to start investing in 23andme Holding Co stocks?

To start investing in 23andme Holding Co, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is today's market capitalisation of 23andme Holding Co?

Today's market capitalisation of 23andme Holding Co ME is 15.2M

Who is the Chief Executive Officer (CEO) of 23andme Holding Co ?

Mr. Guy Chayoun is the current Chief Executive Officer (CEO) of 23andme Holding Co.